Research output
- 9 Article
-
Post-Tuberkulose-Lungenerkrankung
Translated title of the contribution :Post-tuberculosis lung disease Research output: Contribution to journal › Article › peer-review
Open Access -
Secondary laryngeal manifestation of cavitary pulmonary tuberculosis
Neuboeck, M. J., Poier-Fabian, N., Doppler, S. & Salzer, H. J. F., Feb 2026, In: Infection. 54, 1, p. 559-562 4 p.Research output: Contribution to journal › Article › peer-review
-
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease
Neuböck, M., Lange, C. & Salzer, H., 29 Jan 2024, In: Semin Respir Crit Care Med. 45, 1, p. 102-113 12 p.Research output: Contribution to journal › Article › peer-review
-
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation
Heber, S., Pereyra, D., Schrottmaier, W., Santol, J., Rumpf, B., Pawelka, E., Traugott, M., Neuböck, M., Schörgenhofer, C., Seitz, T., Firbas, C., Karolyi, M., Jilma, B., Bellmann-Weiler, R., Salzer, H., Zoufaly, A., Gleiss, A. & Assinger, A., 24 Jan 2022, In: Frontiers in Cellular and Infection Microbiology. 11, 10 p., 795026.Research output: Contribution to journal › Article › peer-review
-
Ciprofloxacin-Resistant Pseudomonas aeruginosa Lung Abscess Complicating COVID-19 Treated with the Novel Oral Fluoroquinolone Delafloxacin
Panholzer, J., Neuböck, M., Shao, G., Heldt, S., Winkler, M., Lamprecht, B. & Salzer, H., Feb 2022, In: Case Reports in Pulmonology. 2022, 5 p., 1008330.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 3 Active
-
A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options
Salzer, H. (PI), Neuböck, M. (Researcher), Kainz, S. (Administration), Zaunmair, P. (Administration) & Gattringer, S. (Administration)
17.02.2026 → 16.02.2027
Project: Clinical studies › Clinical Study (Industry project)
-
FORWARD-IM: An interventional Phase 3, open-label, two-cohort study to investigate the efficacyand safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds
Salzer, H. (PI), Eimer, J. (Researcher), Neuböck, M. (Researcher), Taurian, S. (Researcher), Zaunmair, P. (Administration) & Kainz, S. (Administration)
27.08.2025 → 26.08.2028
Project: Clinical studies › Clinical Study (Industry project)
-
FAST-IC: An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis
Salzer, H. (Researcher), Eimer, J. (PI), Neuböck, M. (Researcher), Kainz, S. (Administration) & Zaunmair, P. (Administration)
28.02.2025 → 27.02.2028
Project: Clinical studies › Clinical Study (Industry project)
Activities
-
Klinische Infektiologie in Linz
Neuböck, M. (Speaker)
11 Nov 2025Activity: Talk or presentation › Other talk or presentation › science-to-public
-
Update zu Tuberkulose-Epidemiologie und Post-tuberculosis lung disease
Neuböck, M. (Speaker)
18 Oct 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Wenn sich die Leber infiziert: mehr als nur ein Nebenschauplatz
Neuböck, M. (Speaker)
17 May 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Suggestion for PTLD-Screening in Vietnam
Neuböck, M. (Speaker)
15 Apr 2025Activity: Talk or presentation › Other talk or presentation › science-to-science
-
Hepatic involvement in an immunocompetent patient with tuberculous lymphadenitis
Neuböck, M. (Speaker)
20 Mar 2025Activity: Talk or presentation › Poster presentation › science-to-science